STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
148
13F, latest reported quarter
What the filings say about PLUS
Insiders, 180 days
-$2.0M net sold
3 sellers · 31% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$1.8M
13 notices
Eplus insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, EPLUS INC insiders sold a net $2.0M of stock across 110 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
27 earlier Form 4 trades (code P or S) here by this insider (27 sales), the last on Oct 12, 2026.
The trade is 2.6% of the 81,981 shares held after it.
1 other insider sold within 30 days.
148 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF FINANCIAL OFFICER Marion Elaine D sold about $202.9K of PLUS under a 10b5-1 plan on Oct 13, 2026; 1 other insider sold within 30 days and 148 funds added in the latest 13F quarter.
27 earlier Form 4 trades (code P or S) here by this insider (27 sales), the last on Oct 12, 2026.
The trade is 3.0% of the 79,604 shares held after it.
1 other insider sold within 30 days.
148 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF FINANCIAL OFFICER Marion Elaine D sold about $229.9K of PLUS under a 10b5-1 plan on Oct 13, 2026; 1 other insider sold within 30 days and 148 funds added in the latest 13F quarter.
27 earlier Form 4 trades (code P or S) here by this insider (27 sales), the last on Oct 12, 2026.
The trade is 0.4% of the 79,259 shares held after it.
1 other insider sold within 30 days.
148 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF FINANCIAL OFFICER Marion Elaine D sold about $33.6K of PLUS under a 10b5-1 plan on Oct 13, 2026; 1 other insider sold within 30 days and 148 funds added in the latest 13F quarter.
26 earlier Form 4 trades (code P or S) here by this insider (26 sales), the last on Aug 4, 2026.
The trade is 0.2% of the 84,101 shares held after it.
1 other insider sold within 30 days.
148 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF FINANCIAL OFFICER Marion Elaine D sold about $15.0K of PLUS under a 10b5-1 plan on Oct 12, 2026; 1 other insider sold within 30 days and 148 funds added in the latest 13F quarter.
51 earlier Form 4 trades (code P or S) here by this insider (51 sales), the last on Sep 22, 2026.
The trade is 0.0% of the 67,036 shares held after it.
1 other insider sold within 30 days.
148 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF OPERATING OFFICER RAIGUEL DARREN S sold about $558 of PLUS under a 10b5-1 plan on Oct 1, 2026; 1 other insider sold within 30 days and 148 funds added in the latest 13F quarter.
110 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
PLUS planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
Marion Elaine D
Filed 2026-10-13
$15.0K
Marion Elaine D
Filed 2026-10-13
$466.4K
RAIGUEL DARREN S
Filed 2026-10-01
$558
RAIGUEL DARREN S
Filed 2026-09-22
$93
RAIGUEL DARREN S
Filed 2026-09-16
$13.0K
PLUS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Argent Focused Small Cap ETF
$923.3K position · as of 2026-05-29
3.6%
ICON HEALTH AND INFORMATION TECHNOLOGY FUND
$2.5M position · as of 2026-06-30
2.6%
AMG River Road Small Cap Value Fund
$23.8M position · as of 2026-07-31
2.4%
Touchstone Funds Group Trust-Touchstone Small Cap Fund
$6.0M position · as of 2026-06-30
2.4%
Pear tree polaris small cap fund
$2.3M position · as of 2026-06-30
2.3%
Nicholas Limited Edition, Inc.
$7.6M position · as of 2026-07-31
2.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Marron
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$8.5M
$10.1M
$3.2M
+52%
+34%
2024
$6.4M
$5.5M
$3.6M
+95%
+72%
2023
$5.7M
$8.2M
$3.2M
+151%
+99%
2022
$4.4M
$3.8M
$2.6M
+57%
+87%
2021
$4.9M
$5.5M
$2.8M
+79%
+97%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $2.0M sold by insiders over 180 days, 148 funds added last quarter, $1.8M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.5B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM PLUS
FY Mar 2026
$2.4B
FY Mar 2025
$2.1B
FY Mar 2024
$2.2B
FY Mar 2023
$2.1B
FY Mar 2022
$1.8B
Jun 2026
$649.1M
Mar 2026
$581.6M
Dec 2025
$614.8M
Sep 2025
$608.8M
Jun 2025
$642.8M
Mar 2025
$498.1M
Dec 2024
$511.0M
Sep 2024
$515.2M
At each fiscal year end
Single quarter
Net margin, TTM
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Net margin, TTM PLUS
FY Mar 2026
n/a
FY Mar 2025
+5.1%
FY Mar 2024
+5.3%
FY Mar 2023
+5.6%
FY Mar 2022
+5.7%
Jun 2026
+4.7%
Mar 2026
+4.3%
Dec 2025
+5.7%
Sep 2025
+5.7%
Jun 2025
+6.6%
Mar 2025
+4.4%
Dec 2024
+4.7%
Sep 2024
+6.1%
At each fiscal year end
Single quarter
Free cash flow, TTM
n/a
capex not filed for the four quarters
Free cash flow, TTM PLUS
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
$75.6M
Mar 2026
$103.8M
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
-$99.8M
Mar 2025
$159.1M
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Debt to equity
0.04x
long-term debt only, 2025-03-31 (15 months older than the period end); equity 2026-06-30
Debt to equity PLUS
FY Mar 2026
0.04x
FY Mar 2025
0.04x
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
0.04x
Mar 2026
0.04x
Dec 2025
0.04x
Sep 2025
0.04x
Jun 2025
0.04x
Mar 2025
0.04x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.53x
TTM operating cash flow over long-term debt only, 2025-03-31 (15 months older than the period end)
Cash flow to debt PLUS
FY Mar 2026
-3.00x
FY Mar 2025
7.79x
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
1.53x
Mar 2026
-3.00x
Dec 2025
-1.55x
Sep 2025
2.40x
Jun 2025
2.74x
Mar 2025
7.79x
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on equity PLUS
FY Mar 2026
n/a
FY Mar 2025
+11.2%
FY Mar 2024
+14.1%
FY Mar 2023
+16.2%
FY Mar 2022
+17.0%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
+13.3%
Sep 2025
+12.4%
Jun 2025
+12.4%
Mar 2025
+11.2%
Dec 2024
+11.6%
Sep 2024
+12.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on assets PLUS
FY Mar 2026
n/a
FY Mar 2025
+5.9%
FY Mar 2024
+7.7%
FY Mar 2023
+9.0%
FY Mar 2022
+9.2%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
+7.5%
Sep 2025
+7.1%
Jun 2025
+6.9%
Mar 2025
+5.9%
Dec 2024
+6.4%
Sep 2024
+6.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on invested capital PLUS
FY Mar 2026
n/a
FY Mar 2025
+11.0%
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
+15.1%
Sep 2025
+12.9%
Jun 2025
+13.5%
Mar 2025
+11.0%
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
the filed year and its quarters do not reconcile, so the trailing figure is withheld
Return on capital employed PLUS
FY Mar 2026
n/a
FY Mar 2025
+9.6%
FY Mar 2024
+14.5%
FY Mar 2023
+17.8%
FY Mar 2022
+22.3%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
+14.4%
Sep 2025
+12.2%
Jun 2025
+10.4%
Mar 2025
+9.6%
Dec 2024
+7.8%
Sep 2024
+10.3%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
20.03x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing PLUS
FY Mar 2026
14.44x
FY Mar 2025
15.53x
FY Mar 2024
17.85x
FY Mar 2023
10.92x
FY Mar 2022
14.30x
Jun 2026
17.49x
Mar 2026
14.44x
Dec 2025
17.23x
Sep 2025
15.21x
Jun 2025
15.95x
Mar 2025
15.53x
Dec 2024
18.52x
Sep 2024
23.99x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$2.1B
market value at close 2026-10-23 on 2026-07-30 shares, plus long-term debt only, 2025-03-31 (15 months older than the period end), minus cash 2026-06-30
Enterprise value PLUS
FY Mar 2026
$1.6B
FY Mar 2025
$1.3B
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
$1.8B
Mar 2026
$1.6B
Dec 2025
$2.0B
Sep 2025
$1.5B
Jun 2025
$1.5B
Mar 2025
$1.3B
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
capex not filed for the four quarters
FCF yield PLUS
FY Mar 2026
n/a
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
n/a
FY Mar 2022
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
3.77x
P/E over trailing EPS growth of 5%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing PLUS
FY Mar 2026
0.44x
FY Mar 2025
n/a
FY Mar 2024
n/a
FY Mar 2023
0.75x
FY Mar 2022
n/a
Jun 2026
3.29x
Mar 2026
0.44x
Dec 2025
0.62x
Sep 2025
1.09x
Jun 2025
1.79x
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
PLUS ranks highest on financial health (83rd percentile) and growth (70th), and lowest on insider conviction (23rd), among Wholesale & Retail peers.
Financial health
83
Inputs
Debt to equity0.04x · 80 pct, sector of 222
Cash flow to debt1.53x · 86 pct, sector of 210
Growth
70
Inputs
Revenue growth, YoY+22.1% · 85 pct, sector of 311
Backlog growth, YoY+7.8% · 55 pct, universe of 854
Insider conviction
23
Inputs
Net Form 4 buying (codes P and S), 180d-$1.4M · 45 pct, sector of 187
Insider buyers, 180d0 · 0 pct, sector of 189
Institutional and government
61
Inputs
Funds adding, latest quarter148 · 61 pct, sector of 234
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
62
Inputs
Short interest, % of float+5.5% · 46 pct, sector of 320
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 242
New text in Risk Factors, latest 10-K+12.8% · 41 pct, sector of 226
2 not measured: Profitability, US patents
Profitability needs 2 of 4 inputs, 0 present: the filed year and its quarters do not reconcile, so the trailing figure is withheld
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
PLUS filings, in plain words
Are Eplus insiders buying or selling PLUS?
In the 180 days to 2026-10-28, Eplus insiders were net sellers, a net $2.0M across purchases and sales reported on Form 4, by 3 sellers.
Are there planned insider sales of PLUS?
Yes. 13 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $1.8M of stock; the latest, by Marion Elaine D, was filed 2026-10-13.
Read the full summary
In the 180 days to 2026-10-28, Eplus insiders were net sellers of PLUS, a net $2.0M across purchases and sales reported on Form 4 by 3 sellers. 31% of the 32 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Insiders filed 13 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $1.8M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.